Evidence map›Paper›PMID 31164653›Full record

ArticleNature communications2019

Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.

Manav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, Roland Seiler, Craig Furman, Htoo Zarni Oo, Michael Seiler, Sean Irwin, Vanitha Subramanian, Jaya Julie Joshi and 29 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

Manav KorpalH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. Manav.korpal@outlook.com.
Xiaoling PuyangH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Zhenhua Jeremy WuH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Roland SeilerDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Craig FurmanH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Htoo Zarni OoDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Michael SeilerH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Sean IrwinH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Vanitha SubramanianH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Jaya Julie JoshiH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Chris K WangDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Victoria RimkunasH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Davide TortoraDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Hua YangEisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA.
Namita KumarEisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA.
Galina KuznetsovEisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA.
Mark MatijevicEisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA.
Jesse ChowEisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA.
Pavan KumarH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Jian ZouH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Jacob FealaH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Laura CorsonH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Ryan HenryH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Anand SelvarajH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Allison DavisH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Kristjan BloudoffH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
James DouglasDepartment of Urology, University Hospital of Southampton, Hampshire, SO16 6YD, UK.
Bernhard KissDepartment of Urology, University of Bern, Bern, CH-3010, Switzerland.
Morgan RobertsDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Ladan FazliDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Peter C BlackDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Peter FekkesH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Peter G SmithH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Markus WarmuthH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Lihua YuH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Ming-Hong HaoH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Nicholas LarsenH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA.
Mads DaugaardDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9.
Ping ZhuH3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. Ping_Zhu@h3biomedicine.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31164653
PMCPMC6547709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.